Tonix Pharmaceuticals Holding Corp.(NASDAQ : TNXP)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -0.26% | 165.19 | 0.7% | $1305.30m | |
| LLY | Eli Lilly & Co. | 0.57% | 331.78 | 1.1% | $1072.82m | |
| ABBV | AbbVie, Inc. | 0.94% | 143.33 | 1.9% | $877.03m | |
| PFE | Pfizer Inc. | -0.47% | 44.25 | 0.9% | $815.29m | |
| BMY | Bristol-Myers Squibb Co. | 0.34% | 71.45 | 1.0% | $767.68m | |
| MRK | Merck & Co., Inc. | 0.01% | 88.40 | 0.7% | $706.05m | |
| AZN | AstraZeneca Plc | -0.54% | 56.73 | 1.0% | $402.73m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | -0.11% | 201.02 | 8.2% | $225.00m | |
| GSK | GSK Plc | -1.01% | 30.40 | 0.3% | $210.45m | |
| NVS | Novartis AG | -1.11% | 77.36 | 0.2% | $209.93m | |
| IDXX | IDEXX Laboratories, Inc. | 0.44% | 350.12 | 3.9% | $189.64m | |
| GBT | Global Blood Therapeutics, Inc. | 0.00% | 68.49 | 5.4% | $183.92m | |
| HZNP | Horizon Therapeutics Plc | 1.35% | 67.05 | 5.4% | $182.38m | |
| NVO | Novo Nordisk A/S | 0.63% | 106.04 | 0.1% | $132.75m | |
| SRPT | Sarepta Therapeutics, Inc. | -0.76% | 110.62 | 12.4% | $132.70m |
Company Profile
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.